Corbus Pharmaceuticals Holding (CRBP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $69.86M
Last updated: Nov 17, 2026 at 11:04 AM ET
Corbus Pharmaceuticals Holding (CRBP) Competitors
The companies most similar to Corbus Pharmaceuticals Holding are Coherus BioSciences (CHRS), Connect Biopharma Holdings (CNTB) and Coya Therapeutics, Inc. Common Stock (COYA). By market cap, Corbus Pharmaceuticals Holding ranks 8th of the 13 companies on this page; Codexis (CDXS) is the largest at $127.13M.
Peer Comparison
CRBP's ROIC of -106.7% is above the peer median of -144.8%, and its revenue growth of -100.0% is below the median of 4.4%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holding (CRBP) | $69.86M | N/A | 13.9x | 0.0% | -106.7% | -100.0% | 0.00% |
| Coherus BioSciences Inc (CHRS) | $81.21M | N/A | 1.5x | -253.4% | -144.8% | 23.4% | 0.00% |
| Connect Biopharma Holdings Ltd (CNTB) | $42.65M | N/A | 13.6x | 0.0% | N/A | 5667.0% | 0.00% |
| Coya Therapeutics, Inc. Common Stock (COYA) | $73.42M | N/A | 15.0x | 0.0% | N/A | -93.4% | 0.00% |
| Cognition Therapeutics Inc (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Rallybio Corp (RLYB) | $88.03M | N/A | 203.1x | 6177.0% | N/A | 0.0% | 0.00% |
| Cardiff Oncology Inc (CRDF) | $56.49M | N/A | 115.5x | 0.0% | N/A | -14.1% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Codexis Inc (CDXS) | $127.13M | N/A | N/A | -21.8% | N/A | 124.0% | 0.00% |
| Champions Oncology Inc (CSBR) | $65.49M | N/A | 1.0x | -1.9% | N/A | 8.8% | 0.00% |
| Foghorn Therapeutics Inc (FHTX) | $124.12M | 40.1x | 1.1x | 8.4% | N/A | 925.0% | 0.00% |
| Gossamer Bio Inc (GOSS) | $67.10M | N/A | 0.9x | -159.5% | 147.4% | 189.1% | 0.00% |
| NRX Pharmaceuticals Inc (NRXP) | $95.58M | N/A | 23.8x | 0.0% | N/A | 0.0% | 0.00% |
| Peer median | $77.01M | 40.1x | 13.6x | 0.0% | -144.8% | 4.4% | 0.00% |
Similar Companies
These are the 12 companies most similar to Corbus Pharmaceuticals Holding, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Coherus BioSciences Inc (CHRS) | Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States. | CHRS competitors |
| Connect Biopharma Holdings Ltd (CNTB) | Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, is focused on the discovery and development of immune modulators... | CNTB competitors |
| Coya Therapeutics, Inc. Common Stock (COYA) | Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). | COYA competitors |
| Cognition Therapeutics Inc (CGTX) | Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting... | CGTX competitors |
| Rallybio Corp (RLYB) | Rallybio Corp is a clinical-stage biotechnology company focused on developing innovative therapies for rare diseases... | RLYB competitors |
| Cardiff Oncology Inc (CRDF) | Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. | CRDF competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| Codexis Inc (CDXS) | Codexis, Inc. discovers, develops and sells biocatalysts. The company is headquartered in Redwood City, California. | CDXS competitors |
| Champions Oncology Inc (CSBR) | Champions Oncology, Inc. develops and sells technology products and solutions to customize the development and use of cancer drugs in the United States. | CSBR competitors |
| Foghorn Therapeutics Inc (FHTX) | Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs that target genetically determined dependencies within... | FHTX competitors |
| Gossamer Bio Inc (GOSS) | Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing... | GOSS competitors |
| NRX Pharmaceuticals Inc (NRXP) | NRx Pharmaceuticals, Inc., a clinical-stage small molecule pharmaceutical company... | NRXP competitors |
Frequently Asked Questions About CRBP
Who are Corbus Pharmaceuticals Holding's main competitors?
The companies most similar to Corbus Pharmaceuticals Holding include Coherus BioSciences (CHRS), Connect Biopharma Holdings (CNTB), Coya Therapeutics, Inc. Common Stock (COYA), Cognition Therapeutics (CGTX) and Rallybio (RLYB), listed from the closest match.
Who is Corbus Pharmaceuticals Holding's biggest competitor?
Codexis (CDXS) is the largest of the similar companies at $127.13M; Coherus BioSciences (CHRS) is the closest match by business profile, size, sector and industry.
How does CRBP stock compare with its competitors?
CRBP's P/S is 13.9x against a peer median of 13.6x; its net margin is 0.0% against a peer median of 0.0%.
Which of Corbus Pharmaceuticals Holding's competitors pays a higher dividend?
Corbus Pharmaceuticals Holding pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Corbus Pharmaceuticals Holding bigger than its competitors?
No. Corbus Pharmaceuticals Holding is 8th by market cap among the 13 companies on this page; the largest is Codexis (CDXS) at $127.13M.
CRBP pages: Overview, Earnings, Forecast, Financials, Competitors